Andrew Chi, MD, PhD at NYU Langone Medical Center Explains Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M MutationÂ
